Molecular biology of MIS and its receptors

Journal of Andrology

Volumn 17, Issue 4, 1996, Pages 336-341

  Teixeira, Jose ^a   Donahoe, Patricia K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

AMINO ACID SEQUENCE; EMBRYO DEVELOPMENT; EMBRYONIC STRUCTURES; HORMONAL REGULATION; LEYDIG CELL; MOLECULAR CLONING; MUELLERIAN DUCT; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SEX DIFFERENTIATION; SHORT SURVEY;

FEMALE; GENE EXPRESSION REGULATION; GLYCOPROTEINS; GROWTH INHIBITORS; HUMANS; MALE; MULLERIAN DUCTS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, PEPTIDE; TESTICULAR HORMONES;

EID: 0029847326     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (21)

1. Baarends WM, Hoogerbrugge JW, Post M, Visser JA, De Rooij DG, Parvinen M, Themmen AP, Grootegoed JA. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression during postnatal testis development and in the adult testis of the rat. Endocrinology 1995;136(12):5614-5622.
2. Baarends WM, van Helmond MJL, van der Schoot PJCM, et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct. Development 1994;120:189-197.
3. Baker ML, Hutson JM. Serum levels of mullerian inhibiting substance in boys throughout puberty and in the first two years of life. J Clin Endocrinol Metab 1993;76(1):245-247.
4. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK, Wang XF. A transforming growth factor beta type I receptor that signals to activate gene expression. Science 1994;263(5143):87-89.
5. Behringer RR, Finegold MJ, Cate RL. Múllerian-inhibiting substance function during mammalian sexual development. Cell 1994;79(3): 415-425.
6. Bogan JS, Page DC, Ovary? Testis? - A mammalian dilemma. Cell 1994;76:603-607.
7. Cate RL, Donahoe PK, MacLaughlin DT. Müllerian inhibiting substance. In: Sporn MB, Roberts AB, eds. Peptide Growth Factors and Their Receptors. Berlin: Springer-Verlag; 1990;95/II:179-210.
8. Cate RL, Mattaliano RJ, Hession C, Tizard R, et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 1986;45:685-698.
9. di Clemente N, Wilson C, Faure E, Boussin L, et al. Cloning, expression and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol 1994;8:1006-1020.
10. Haqq CM, King CY, Ukiyama E, Falsafi S, Haqq TN, Donahoe PK, Weiss MA. Molecular basis of mammalian sexual determination: activation of Múllerian inhibiting substance gene expression by SRY [published erratum appears in Science 1995;267(5196):317]. Science 1994;266(5190):1494-1500.
11. He WW, Gustafson ML, Hirobe S, Donahoe PK. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. Dev Dyn 1993;196(2):133-142.
12. Imbeaud S, Faure E, Lamarre I, Mattei MG, et al. Insensitivity to anti-Müllerian hormone due to a mutation in the human anti-Müllerian hormone receptor. Nature Gen 1995; 11:382-388.
13. Jost A. Recherches sur la différenciation sexuelle de l'embryon de lapin. Arch Anat Micro Morph Exp 1947;36:271-315.
14. Lee MM, Donahoe PK. Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 1993;14(2): 152-164.
15. Lee MM, Donahoe PK, Hasegawa H, Silverman B, et al. Müllerian inhibiting substance (MIS) in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571-576.
16. Massaguér J, Attisano L, Wrana JL. The TGF-ß family and its composite receptors. Trends Cell Biol 1994;4:172-178.
17. Matzuk MM, Finegold MJ, Mishina Y, Bradley A, Behringer RR. Synergistic effects of inhibins and Müllerian inhibiting substance on testicular tumorigenesis. Mol Endocrinol 1995;9:1337-1345.
18. Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA. Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: a link to the sex determination cascade. Cell 1994;77(5): 651-661.
19. Teixeira JM, He WW, Shah PC, Morikawa N, et al. Developmental expression of a candidate Müllerian inhibiting substance type II receptor. Endocrinology 1996;137(1):160-165.
20. ras farnesyltransferase α subunit in TGF-β and activin signaling. Science 1996;271:1120-1122.
21. Wang T, Donahoe PK, Zervos AS. Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12. Science 1994;265(5172):674-667.